Meto vs. ShedRx: Which Metabolic Health Platform is Right for You?

ShedRx is a telehealth platform focused primarily on helping patients access prescription weight loss medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) through a quick online process. The program is medication-first: patients complete an online quiz, consult with a provider, and — if eligible — are prescribed GLP-1s shipped directly to their door, typically in compounded form. While ShedRx offers simple onboarding and recurring prescription deliveries, it does not offer integrated medical care, long-term behavioral coaching, or broader metabolic health support. Its appeal lies in convenience and speed, especially for people primarily seeking GLP-1s with minimal clinical involvement.

Meto, by contrast, is a fully integrated metabolic health platform built around physician-led care, continuous monitoring, and long-term metabolic improvement. While it also provides access to GLP-1 medications, Meto treats prescriptions as just one part of a larger clinical plan. Each member receives a personalized, medically informed care pathway that may include lab testing, nutrition support, hormonal evaluation, and behavior change — all delivered by a dedicated care team. Unlike ShedRx, Meto’s goal is not just weight loss but restoring long-term metabolic health, especially for those dealing with complex conditions like PCOS, insulin resistance, perimenopause, or chronic inflammation.

Features	Meto	ShedRx
Approach to Care	Medical-led, personalized metabolic and hormonal health care.	Medication-first weight loss with optional telehealth consults.
Use of Technology	AI-powered clinical insights, integrated telehealth, device and lab integrations (e.g., CGMs).	Online quiz, basic telehealth consult, recurring prescription delivery.
Insurance Coverage	Accepts most major insurance providers.	Not insurance-compatible; all services are cash-pay only.
Pricing Model	Copay (insurance-eligible), transparent pricing model.	Flat monthly cash subscription, typically $297–$399/month.
Clinical Team Availability	Licensed physicians, NPs, metabolic health specialists, dietitians, and coaches.	Limited provider interaction focused on prescription approval and renewals.
Availability	U.S.-based, currently expanding.	Available in most U.S. states for qualifying patients.
Program Flexibility	Adaptable care plans tailored to metabolic profiles and health history.	Fixed monthly subscription; focused solely on GLP-1 delivery.
Patient Support	Dedicated care team with medical consultations and check-ins.	Minimal support beyond initial consult and medication shipment.
Mobile & Web Experience	Mobile and web app with dashboard, tracking, and remote patient monitoring.	Website and patient portal for sign-up and medication orders.
Community and Peer Support	Growing provider-supported community with educational resources.	No peer community or support forums offered.

ShedRx is centered around one main goal: helping people access GLP-1 medications quickly and easily. The platform emphasizes simplicity and convenience — you fill out a quiz, attend a brief consult, and receive your prescription. Its approach is transactional and medication-led, appealing to people who already believe GLP-1s are their solution and want minimal friction. There’s no long-term care plan, nutrition coaching, or deep focus on root-cause resolution — the process is about getting a prescription, not treating the underlying metabolic system.

Meto takes a broader view: it’s built around the belief that sustainable weight loss and metabolic health require a deeper understanding of biology. Rather than seeing medication as the endpoint, Meto uses it as a supportive tool within a bigger care strategy — one that includes hormones, labs, food, movement, and stress. The platform is designed for people seeking answers to why their body resists change — not just a short-term fix. In this way, Meto is better aligned with long-term metabolic transformation and healthspan extension.

ShedRx offers basic medical oversight primarily through one-time telehealth evaluations to determine prescription eligibility. Most patient interaction ends after the prescription is issued, with follow-ups focused on medication refills. There is limited support for side effects, titration, or metabolic tracking, and no ongoing engagement with a medical team unless initiated by the patient. The model functions more like a pharmacy than a comprehensive medical platform.

Meto is fully clinical from start to finish. Each member is assigned a provider and supported by a care team, including health coaches and AI-driven monitoring tools. Clinical protocols are rooted in evidence-based guidelines from endocrinology and obesity medicine. Medication management includes titration support, deprescription plans, and full integration with lab testing and wearable data. Medical supervision isn’t an add-on at Meto — it’s the core offering.

ShedRx’s personalization is limited to determining prescription eligibility based on BMI and health history. Patients answer questions during onboarding and may briefly speak with a provider, but there’s no detailed intake, testing, or plan customization beyond the prescribed dosage. Everyone receives essentially the same pathway: monthly compounded medication delivery with refill reminders.

Meto, in contrast, builds each care plan from a personalized foundation. After a deep intake process — including lab work, metabolic screenings, and goal-setting — each patient is matched with a clinical team that adjusts their plan over time. Care adapts based on hormone levels, symptoms, wearable data, and lifestyle factors. Whether your concern is midlife metabolic slowdown, thyroid dysfunction, or post-PCOS weight gain, your Meto plan meets your body where it is.

ShedRx built its brand around fast and direct access to GLP-1 medications like semaglutide and tirzepatide. The process is streamlined and convenient, but lacks a comprehensive framework. There’s minimal context about how to use these medications within a broader health plan — it’s access-first, care-optional. While ShedRx may be a fit for those who are well-informed and want minimal involvement, it may not meet the needs of those who require support with side effects, long-term strategy, or deprescription.

Meto offers access to GLP-1s too — but only as part of a deeper clinical relationship. Every patient is evaluated holistically before a prescription is considered, and those who qualify receive ongoing medical supervision. Meto offers real-time support for side effects, behavioral coaching to optimize outcomes, and deprescription pathways once metabolic function improves. It’s not just about “getting the drug,” but about making it work in harmony with your biology and goals.

ShedRx is best for individuals who already know they want GLP-1 medications and prefer a hands-off, streamlined experience. If you’re not looking for long-term medical care or deeper insight into your metabolic health — and just want access to medications quickly — ShedRx may be sufficient. It’s best for people who are confident managing their own health journey and want minimal touchpoints.

Meto is better suited for people seeking long-term, clinically supervised transformation. If you’ve tried diets, hit plateaus, or are navigating complex issues like insulin resistance, hormonal shifts, or chronic fatigue, Meto offers a team-based approach to help you understand and correct what’s happening in your body. Whether you're starting medication or aiming to eventually come off it, Meto provides the kind of integrated care that supports both the short-term win and the long-term journey.